Skip to content
  • Home
  • Signal News
  • Biopharma Digest
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Regulatory Interactive Calendar
    • Manufacturing Intelligence
  • Contact

Pharminent

 Posted in Manufacturing

Innovent’s CDMO gets green light to make biologics at large Chinese plant

 April 9, 2026

BioSpace

The license, which Innovent’s Altruist business said is the first of its kind, positions the CDMO to support commercial clients as it works to expand the plant’s capacity to 172,000 liters.

ManufacturingRead full story

Post navigation

Kainova expands DT 7012 trial into Europe →
← Oxford BioTherapeutics signs collaboration with Bristol Myers Squibb

Categories

© 2026 Pharminent. All rights reserved.

Design by ThemesDNA.com